Researchers at Erasmus MC have discovered a biomarker in the blood that can predict the progression of Parkinson’s disease. ‘Knowing how severe the disease will be in three years allows doctors to plan treatment much more precisely.
Researchers at Erasmus MC have discovered a biomarker in the blood that can predict the progression of Parkinson’s disease. ‘Knowing how severe the disease will be in three years allows doctors to plan treatment much more precisely.